SPPAM
HZNP
Summit Partners Public Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-873,803
| Closed | -$69.7M | – | 133 |
|
2022
Q2 | $69.7M | Sell |
873,803
-84,178
| -9% | -$6.71M | 3.14% | 2 |
|
2022
Q1 | $101M | Sell |
957,981
-105,255
| -10% | -$11.1M | 3.58% | 2 |
|
2021
Q4 | $115M | Sell |
1,063,236
-25,702
| -2% | -$2.77M | 4.38% | 1 |
|
2021
Q3 | $119M | Buy |
1,088,938
+175,443
| +19% | +$19.2M | 3.74% | 1 |
|
2021
Q2 | $85.5M | Sell |
913,495
-29,898
| -3% | -$2.8M | 3.04% | 1 |
|
2021
Q1 | $86.8M | Sell |
943,393
-34,908
| -4% | -$3.21M | 3.76% | 1 |
|
2020
Q4 | $71.6M | Buy |
978,301
+63,047
| +7% | +$4.61M | 3.18% | 7 |
|
2020
Q3 | $71.1M | Buy |
915,254
+84,608
| +10% | +$6.57M | 3.56% | 3 |
|
2020
Q2 | $46.2M | Buy |
+830,646
| New | +$46.2M | 2.76% | 4 |
|
2017
Q1 | – | Sell |
-210,000
| Closed | -$3.4M | – | 89 |
|
2016
Q4 | $3.4M | Buy |
+210,000
| New | +$3.4M | 0.72% | 42 |
|
2015
Q4 | – | Sell |
-185,000
| Closed | -$3.67M | – | 56 |
|
2015
Q3 | $3.67M | Buy |
185,000
+80,000
| +76% | +$1.59M | 1.39% | 20 |
|
2015
Q2 | $3.65M | Buy |
+105,000
| New | +$3.65M | 1.27% | 22 |
|